Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $19.60 in the prior trading day, Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) closed at $18.88, down -3.67%. In other words, the price has decreased by -$3.67 from its previous closing price. On the day, 0.28 million shares were traded. KNSA stock price reached its highest trading level at $19.6 during the session, while it also had its lowest trading level at $18.86.
Ratios:
Our goal is to gain a better understanding of KNSA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 122.81. For the most recent quarter (mrq), Quick Ratio is recorded 2.95 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on September 13, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On May 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $34.
BofA Securities reiterated its Buy rating for the stock on June 29, 2020, while the target price for the stock was revised from $25 to $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 13 ’25 when Tessari Eben sold 14,000 shares for $18.24 per share. The transaction valued at 255,413 led to the insider holds 88,975 shares of the business.
Tessari Eben bought 14,000 shares of KNSA for $255,390 on Jan 13 ’25. On Dec 16 ’24, another insider, Tessari Eben, who serves as the CHIEF OPERATING OFFICER of the company, sold 23,017 shares for $20.44 each. As a result, the insider received 470,467 and left with 95,975 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KNSA now has a Market Capitalization of 1363166208 and an Enterprise Value of 1149980544. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.55 while its Price-to-Book (P/B) ratio in mrq is 3.12. Its current Enterprise Value per Revenue stands at 2.994 whereas that against EBITDA is -47.128.
Stock Price History:
The Beta on a monthly basis for KNSA is 0.31, which has changed by 0.060032487 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, KNSA has reached a high of $28.15, while it has fallen to a 52-week low of $16.56. The 50-Day Moving Average of the stock is -7.06%, while the 200-Day Moving Average is calculated to be -14.09%.
Shares Statistics:
The stock has traded on average 407.57K shares per day over the past 3-months and 627750 shares per day over the last 10 days, according to various share statistics. A total of 41.52M shares are outstanding, with a floating share count of 39.73M. Insiders hold about 44.98% of the company’s shares, while institutions hold 55.67% stake in the company. Shares short for KNSA as of 1736899200 were 2109178 with a Short Ratio of 5.17, compared to 1734048000 on 3257519. Therefore, it implies a Short% of Shares Outstanding of 2109178 and a Short% of Float of 6.529999999999999.
